BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17047134)

  • 1. Topiramate for binge-eating disorder associated with obesity.
    Tata AL; Kockler DR
    Ann Pharmacother; 2006 Nov; 40(11):1993-7. PubMed ID: 17047134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.
    McElroy SL; Hudson JI; Capece JA; Beyers K; Fisher AC; Rosenthal NR;
    Biol Psychiatry; 2007 May; 61(9):1039-48. PubMed ID: 17258690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity.
    Kotwal R; Guerdjikova A; McElroy SL; Keck PE
    Hum Psychopharmacol; 2006 Oct; 21(7):425-31. PubMed ID: 16941522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate use in obese patients with binge eating disorder: an open study.
    Appolinario JC; Fontenelle LF; Papelbaum M; Bueno JR; Coutinho W
    Can J Psychiatry; 2002 Apr; 47(3):271-3. PubMed ID: 11987480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
    Dalai SS; Adler S; Najarian T; Safer DL
    Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
    Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
    J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review.
    Arbaizar B; Gómez-Acebo I; Llorca J
    Gen Hosp Psychiatry; 2008; 30(5):471-5. PubMed ID: 18774432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
    McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
    Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.
    Grilo CM; Reas DL; Mitchell JE
    Curr Psychiatry Rep; 2016 Jun; 18(6):55. PubMed ID: 27086316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
    McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
    J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate for binge eating disorder.
    De Bernardi C; Ferraris S; D'Innella P; Do F; Torre E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):339-41. PubMed ID: 15694244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.
    Kramer CK; Leitão CB; Pinto LC; Canani LH; Azevedo MJ; Gross JL
    Obes Rev; 2011 May; 12(5):e338-47. PubMed ID: 21438989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of topiramate in patients with traumatic brain injury and obesity--a case series.
    Dolberg OT; Barkai G; Gross Y; Schreiber S
    Psychopharmacology (Berl); 2005 Jun; 179(4):838-45. PubMed ID: 15619108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of binge eating disorder: update review and synthesis.
    Reas DL; Grilo CM
    Expert Opin Pharmacother; 2015; 16(10):1463-78. PubMed ID: 26044518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binge eating disorder: the search for better treatments.
    Yager J
    Am J Psychiatry; 2008 Jan; 165(1):4-6. PubMed ID: 18178748
    [No Abstract]   [Full Text] [Related]  

  • 18. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New obesity agents: lorcaserin and phentermine/topiramate.
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.